LIFEVANTAGE CORP Employee Count
The employee counts LIFEVANTAGE CORP states in its annual reports on SEC EDGAR, each as filed.
- 2026-06-30: Employees (as filed) 223; Filing 2026-08-27; Lease expense per employee $8,372.20.
- 2025-06-30: Employees (as filed) 238; Filing 2025-09-04; Lease expense per employee $8,596.64.
- 2024-06-30: Employees (as filed) 222; Filing 2024-08-28; Lease expense per employee $9,612.61.
- 2013-06-30: Employees (as filed) 238; Filing 2013-09-12; Lease expense per employee $7,563.03.
- Available history
- 2012-06-30 to 2026-06-30
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2026-06-30 | 223 full-time | 2026-08-27 | $8,372.20 total lease cost |
| 2025-06-30 | 238 full-time | 2025-09-04 | $8,596.64 total lease cost |
| 2024-06-30 | 222 full-time | 2024-08-28 | $9,612.61 total lease cost |
| 2013-06-30 | 238 full-time | 2013-09-12 | $7,563.03 rent expense, net |
| 2012-06-30 | 139 full-time | 2012-09-10 | $2,877.70 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |